The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project

Daniel J. Sargent,Qian D Shi,Christopher R. Flowers,Norbert Schmitz,Thomas Matthew Habermann,Jocelyne Flament,Tommy Fu,Bertrand Coiffier

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project

2017

Daniel J. Sargent
Qian D Shi
Christopher R. Flowers
Norbert Schmitz
Thomas Matthew Habermann
Jocelyne Flament
Tommy Fu
Bertrand Coiffier

This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL.

Keywords:

Pathology
Diffuse large B-cell lymphoma
Aggressive lymphoma
Biomarker (medicine)
Surrogate endpoint
Medicine
Endpoint Determination
Survival rate
Clinical trial
Oncology
Internal medicine
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations